GPX4 degrader-2
GPX4 degrader-2 is a GPX4 molecular glue degrader and ferroptosis inducer. GPX4 degrader-2 suppresses GPX4 enzyme activity, promotes ubiquitination-dependent proteasomal degradation of GPX4 protein. GPX4 degrader-2 indues ferroptosis, increases lipid ROS and MDA levels, suppresses glutathione levels in cancer cells. GPX4 degrader-2 inhibits cancer cells proliferation and colony formation. GPX4 degrader-2 can be used for the research of colorectal cancer.
For research use only. We do not sell to patients.
- Formula: C30H30ClNO8
- Molecular Weight:568.01
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
GPX4 |
In Vitro
GPX4 degrader-2 (Compound W25) (24-72 h) potently inhibits HCT-116 colorectal cancer cell viability with time-dependent efficacy, achieving IC50 values of 4.17, 2.49 and 2.24 μM after 24. 48 and 72 h treatment[1].
GPX4 degrader-2 (2.5-10 μM; 6 h) dose-dependently suppresses long-term colony formation of HCT-116 colorectal cancer cells and inhibits DNA synthesis[1].
GPX4 degrader-2 (2.5-10 μM; 6-24 h) dose- and time-dependently accumulates lipid ROS in HCT-116 colorectal cancer cells[1].
GPX4 degrader-2 (2.5-10 μM; 24 h) dose-dependently depletes intracellular GSH levels and increases intracellular MDA levels in HCT-116 colorectal cancer cells[1].
GPX4 degrader-2 (2.5-10 μM; 6-24 h) dose-dependently downregulates GPX4 protein expression in HCT-116 colorectal cancer cells by promoting ubiquitin-proteasomal degradation[1].
GPX4 degrader-2 (10 μM; 24 h) promotes ubiquitination of GPX4 protein in HCT-116 colorectal cancer cells[1].
GPX4 degrader-2 (50-100 μM; 2 h) directly binds to GPX4 protein, protecting it from pronase E digestion in HCT-116 colorectal cancer cell lysates[1].
GPX4 degrader-2 inhibits the enzymatic activity of human recombinant GPX4[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HCT-116 colorectal cancer cells
-
Concentration:2.5, 5, 10 μM
-
Incubation Time:6, 12, 24 h
-
Result:Reduced GPX4 protein levels.
Had its GPX4-inhibitory effect reversed by MG132 treatment.
Chemical Information
-
Molecular Weight 568.01
-
Formula C30H30ClNO8
-
SMILES
O=C(OC1=CC=C(C[C@H]2C(OCC2CC3=CC=C(OC)C(OC)=C3)=O)C=C1OC)C4=CC=C(NC(CCl)=O)C=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- GPX4 degrader-2
- Molecular Glues
- Glutathione Peroxidase
- Ferroptosis
- Reactive Oxygen Species (ROS)
- glutathione
- ubiquitin-proteasomal degradation
- human liver microsomes
- malondialdehyde
- GPX4
- lipid reactive oxygen species
- ferroptosis
- colorectal cancer cells
- HCT-116 colorectal cancer cell
- ubiquitination-dependent proteasomal degradation
- Inhibitor
- inhibitor
- inhibit